Hong Kong Pharmaceutical Registration Guide
A practical pathway for drug product registration, trader licences, import/export, and pharmacovigilance—from ElendiLabs, a pharmaceutical and medical device regulatory affairs consultancy.
1. Is your product a pharmaceutical product?
In Hong Kong, classification depends on ingredients and claims. Products with an active pharmaceutical ingredient usually fall under pharmaceutical product rules. Labels with health claims can also bring a product into scope even without an API. The Pharmacy and Poisons Ordinance governs much of this framework.
2. Who applies for registration?
For products manufactured in Hong Kong, the licensed manufacturer or a licensed wholesale dealer working with that manufacturer typically applies. For overseas manufacture, responsibility usually sits with the licensed wholesale dealer who imports, or the Hong Kong branch, subsidiary, agent, or distributor of the overseas manufacturer.
3. Drug / product registration pathway
Initial registration requires a complete dossier meeting safety, efficacy, and quality standards. New applications are submitted through PRS 2.0. After approval and fee payment, you receive the Certificate of Drug/Product Registration. Use official Drug Office guidance notes for document checklists and variation rules (major vs minor).
4. Trader and premises licences
Depending on your activities you may need a Wholesale Dealer Licence (WDL), Manufacturer’s Licence, Authorized Seller of Poisons (ASP) premises certificate, Listed Seller of Poisons (LSP) licence, Antibiotics Permit, and/or dangerous-drugs-related licences. Licence type follows the product class and channel (wholesale, retail, manufacture, import/export).
5. Import and export per shipment
After holding the right trader licence, each import or export typically needs an Import Licence (Form 3) or Export Licence (Form 6) via the Drug Evaluation and Import/Export Control Division. Plan lead times into logistics for each consignment.
6. Pharmacovigilance and recalls
Local serious adverse events should be reported within 15 calendar days under Drug Office industry guidance. Maintain batch, sales, and temperature records for the required retention periods. Recalls and suspected counterfeits need prompt, documented action with the authorities.
Work with our regulatory affairs team
ElendiLabs delivers pharmaceutical and medical device regulatory affairs consulting in-house—registration support, licensing, compliance, and market entry—alongside our vetted consultant marketplace when you need wider coverage.